Administration of growth hormone (GH) has been used successfully in elderly to prevent atrophy during catabolic diseases or following hip fractures (Van der Lely et al
Plaidum S, Patcharatrakul T, Promjampa W, Gonlachanvit S
Taken together, the evidence suggests that class-wide disease modification in Parkinsons, at the compounds and doses tested so far, is unlikely, even if a responder subgroup may yet exist
Additionally, in the trial examining alcohol use disorder, a significant reduction in alcohol consumption was observed only in a specific subgroup of patients with obesity, suggesting that patient characteristics, such as BMI, might influence treatment outcomes
This distinction is important context when interpreting search results and marketing claims in the over-the-counter GLP-1 booster category